Angela Thedinga

Ms. Thedinga is an experienced biopharmaceutical manufacturing executive. She most recently served as Chief Technology Officer of Adverum Biotechnologies, Inc., where she led process development, manufacturing, and supply chain functions supporting the development of ocular gene therapies. Ms. Thedinga joined Adverum in 2019. Previously she held executive roles in manufacturing and supply chain management and strategy at AveXis, now Novartis Gene Therapies, to deliver the first approved gene therapy for spinal muscular atrophy. Her earlier industry experience includes manufacturing strategy roles in bioprocess engineering at Abbott Laboratories and vaccine development at Novartis Vaccines and Diagnostics.

She earned an MBA and MS in Chemical Engineering from the Massachusetts Institute of Technology (MIT), an MPH at the University of North Carolina, Chapel Hill, and a BS in Chemical Engineering from the University of Wisconsin. She is a founding member of Chief, an organization focused on connecting and supporting women executive leaders.